
“The quality and coverage of B2B contact database are very impressive...”
Mark J.
`
+4
Hinova (688302.SH) is an international and clinical-stage pharmaceutical company focused on developing new therapeutics for cancers and metabolic syndromes through PROTAC and deuteration technology. We are committed to the discovery and development of innovative drugs with global interests that meet the significant clinical needs. Hinova pharma has 4 core R&D platforms, which are PROTAC (PROteolysis Targeting Chimera) platform, deuteration platform, novel target discovery and validation platform, and lead compound optimization screening platform. We have submitted more than 200 PCT and national patents, with more than 60 patents granted in China and in the globe, such as the US, EU, and...
Rotac targeted protein degradation(tpd)platform,deuterated drug r&d platform,anti-cancer drug,innovative drug,cancer,metabolic disease,prostate cancer,hyperuricemia,and gout
Hinova pharmaceuticals inc operates in the Biotechnology industry.
Hinova pharmaceuticals inc's revenue is < 1m
Hinova pharmaceuticals inc has 11 - 50 employees.
Get Started with the Free Forever plan! No credit card needed. Enjoy up to 10,000 free email credits per month at no cost.
Start Prospecting from Clodura.AI's database of 600M+ verified B2B contacts and 120M+ direct dials along with 18M+ companies' org charts.
Unlock the prospect's contact details, including verified email, direct dials, add them to cadence, and close more deals.